U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ROMILKIMAB
INN   USAN  
Official Name English
SAR-156597
Preferred Name English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS INTERLEUKIN-13 (IL-13)) AND ANTI-(HOMO SAPIENS INTERLEUKIN-4 (B-CELL STIMULATORY FACTOR 1, BINETRAKIN, IL-4)) CHIMERIC AND HUMANIZED MONOCLONAL ANTIBODY, BISPECIFIC, TETRAVALENT .GAMMA.1 HEAVY CHAIN (1-577) (VH
Common Name English
SAR156597
Code English
HUTBTI3_2_1
Common Name English
IMMUNOGLOBULIN G4, BISPECIFIC, ANTI-(HUMAN INTERLEUKIN 4/INTERLEUKIN 13)(HUMANIZED CLONES HU8D4-8-AND HUBB13-CONTG. .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED CLONES HU8D4-8-AND HUBB13-CONTG. .KAPPA.-CHAIN, DIMER
Common Name English
romilkimab [INN]
Common Name English
ROMILKIMAB [USAN]
Common Name English
Romilkimab [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 342811
Created by admin on Tue Apr 01 22:20:38 GMT 2025 , Edited by admin on Tue Apr 01 22:20:38 GMT 2025
FDA ORPHAN DRUG 629518
Created by admin on Tue Apr 01 22:20:38 GMT 2025 , Edited by admin on Tue Apr 01 22:20:38 GMT 2025
Code System Code Type Description
USAN
FG-222
Created by admin on Tue Apr 01 22:20:38 GMT 2025 , Edited by admin on Tue Apr 01 22:20:38 GMT 2025
PRIMARY
FDA UNII
O8HNJ174XS
Created by admin on Tue Apr 01 22:20:38 GMT 2025 , Edited by admin on Tue Apr 01 22:20:38 GMT 2025
PRIMARY
NCI_THESAURUS
C174791
Created by admin on Tue Apr 01 22:20:38 GMT 2025 , Edited by admin on Tue Apr 01 22:20:38 GMT 2025
PRIMARY
INN
10622
Created by admin on Tue Apr 01 22:20:38 GMT 2025 , Edited by admin on Tue Apr 01 22:20:38 GMT 2025
PRIMARY
SMS_ID
100000181762
Created by admin on Tue Apr 01 22:20:38 GMT 2025 , Edited by admin on Tue Apr 01 22:20:38 GMT 2025
PRIMARY
CAS
1399584-78-1
Created by admin on Tue Apr 01 22:20:38 GMT 2025 , Edited by admin on Tue Apr 01 22:20:38 GMT 2025
PRIMARY
ACTIVE MOIETY
ROMILKIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966